Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Panacea Biotec Limited ( (IN:PANACEABIO) ) has issued an update.
Panacea Biotec Limited announced the completion of Mrs. Manjula Upadhyay’s tenure as an Independent Director on March 29, 2025. Her departure marks the end of her second and final term, during which she contributed significantly to the company’s growth. While she will no longer serve on the company’s board, Mrs. Upadhyay will continue her role as a non-executive independent director at Panacea Biotec Pharma Limited, a wholly-owned subsidiary. The company expressed gratitude for her guidance and contributions.
More about Panacea Biotec Limited
Panacea Biotec Limited is a company operating in the pharmaceutical industry, focusing on the development and manufacturing of vaccines and pharmaceutical formulations. It is headquartered in Punjab, India, with a corporate office in New Delhi.
YTD Price Performance: 0.49%
Average Trading Volume: 22,598
Current Market Cap: 26.99B INR
See more data about PANACEABIO stock on TipRanks’ Stock Analysis page.